Sign In
Buy OTIC
$0.0085
+0 (+0%)
At Close: Jul 11, 2023
Otonomy to Report Fourth Quarter and Full Year —…–9 Financial Results and Provide ...
12:00am, Thursday, 20'th Feb 202094 Biggest Movers From Yesterday
10:13am, Wednesday, 12'th Feb 2020
Gainers
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license agreement with Zhejiang HaiChang Biotechnology....
Otonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program
12:30pm, Tuesday, 28'th Jan 2020
Otonomy, Inc. (OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced preclinical results from the company’s gene therapy collab
Otonomy Presents Preclinical Results for GJB— Gene Therapy Collaboration and Cisplatin ...
12:00am, Tuesday, 28'th Jan 2020Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
12:30pm, Thursday, 23'rd Jan 2020
Otonomy, Inc. (OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced multiple presentations at the upcoming Association for Resea
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual ...
12:00am, Thursday, 23'rd Jan 2020Otonomy Provides Corporate and Product Pipeline Update
12:30pm, Thursday, 09'th Jan 2020
Otonomy, Inc. (OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today provided an update on its product pipeline and financial guidance. Co
Otonomy 8-K Includes Press Release With Corporate, Product Pipeline Update
12:00am, Thursday, 09'th Jan 2020Should You Worry About Otonomy, Inc.'s (NASDAQ:OTIC) CEO Salary Level?
05:31pm, Tuesday, 07'th Jan 2020
David Weber has been the CEO of Otonomy, Inc. (NASDAQ:OTIC) since 2010. This analysis aims first to contrast CEO...
The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger
12:55pm, Friday, 03'rd Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 2) Agile Therapeutics Inc (NASDAQ: AGRX (announced the
Will Otonomy Continue to Surge Higher?
12:28pm, Thursday, 02'nd Jan 2020
As of late, it has definitely been a great time to be an investor in Otonomy.
